Cargando…
Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
BACKGROUND: The EP1 receptor for the prostanoid PGE2 is a G-protein coupled receptor that has been shown to contribute to excitotoxic neuronal death. In this study we examined the influence of non-neuronal cells on neuroprotective properties of EP1 receptor antagonists (Ono 8711 and SC 51089). METHO...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649915/ https://www.ncbi.nlm.nih.gov/pubmed/19222857 http://dx.doi.org/10.1186/1742-2094-6-5 |
_version_ | 1782165073195696128 |
---|---|
author | Carlson, Noel G Rojas, Monica A Black, John-David Redd, Jonathan W Hille, John Hill, Kenneth E Rose, John W |
author_facet | Carlson, Noel G Rojas, Monica A Black, John-David Redd, Jonathan W Hille, John Hill, Kenneth E Rose, John W |
author_sort | Carlson, Noel G |
collection | PubMed |
description | BACKGROUND: The EP1 receptor for the prostanoid PGE2 is a G-protein coupled receptor that has been shown to contribute to excitotoxic neuronal death. In this study we examined the influence of non-neuronal cells on neuroprotective properties of EP1 receptor antagonists (Ono 8711 and SC 51089). METHODS: Primary neuronal cultures systems with or without non-neuronal cells were used to examine how the neuroprotective properties of EP1 antagonists were influenced by non-neuronal cells. The influence of astrocytes or microglia were individually tested in excitotoxicity assays using a co-culture system with these cells grown on permeable transwell inserts above the neuronal-enriched cultures. The influence of microglia on PGE2 synthesis and EP1 receptor expression was examined. RESULTS: EP1 antagonists were neuroprotective in neuronal-enriched cultures (> 90% neurons) but not in mixed cultures (30% neurons plus other non-neuronal cells). Co-cultures of microglia on permeable transwell inserts above neuronal-enriched cultures blocked neuroprotection by EP1 antagonists. Incubation of microglia with neuronal-enriched cultures for 48 hours prior to NMDA challenge was sufficient to block neuroprotection by EP1 antagonists. The loss of neuroprotection by EP1 antagonists was accompanied by a decrease of neuronal EP1 expression in the nucleus in cultures with microglia present. CONCLUSION: These findings demonstrate microglial modulation of neuronal excitotoxicity through interaction with the EP1 receptor and may have important implications in vivo where microglia are associated with neuronal injury. |
format | Text |
id | pubmed-2649915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26499152009-03-03 Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor Carlson, Noel G Rojas, Monica A Black, John-David Redd, Jonathan W Hille, John Hill, Kenneth E Rose, John W J Neuroinflammation Research BACKGROUND: The EP1 receptor for the prostanoid PGE2 is a G-protein coupled receptor that has been shown to contribute to excitotoxic neuronal death. In this study we examined the influence of non-neuronal cells on neuroprotective properties of EP1 receptor antagonists (Ono 8711 and SC 51089). METHODS: Primary neuronal cultures systems with or without non-neuronal cells were used to examine how the neuroprotective properties of EP1 antagonists were influenced by non-neuronal cells. The influence of astrocytes or microglia were individually tested in excitotoxicity assays using a co-culture system with these cells grown on permeable transwell inserts above the neuronal-enriched cultures. The influence of microglia on PGE2 synthesis and EP1 receptor expression was examined. RESULTS: EP1 antagonists were neuroprotective in neuronal-enriched cultures (> 90% neurons) but not in mixed cultures (30% neurons plus other non-neuronal cells). Co-cultures of microglia on permeable transwell inserts above neuronal-enriched cultures blocked neuroprotection by EP1 antagonists. Incubation of microglia with neuronal-enriched cultures for 48 hours prior to NMDA challenge was sufficient to block neuroprotection by EP1 antagonists. The loss of neuroprotection by EP1 antagonists was accompanied by a decrease of neuronal EP1 expression in the nucleus in cultures with microglia present. CONCLUSION: These findings demonstrate microglial modulation of neuronal excitotoxicity through interaction with the EP1 receptor and may have important implications in vivo where microglia are associated with neuronal injury. BioMed Central 2009-02-17 /pmc/articles/PMC2649915/ /pubmed/19222857 http://dx.doi.org/10.1186/1742-2094-6-5 Text en Copyright © 2009 Carlson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Carlson, Noel G Rojas, Monica A Black, John-David Redd, Jonathan W Hille, John Hill, Kenneth E Rose, John W Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor |
title | Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor |
title_full | Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor |
title_fullStr | Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor |
title_full_unstemmed | Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor |
title_short | Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor |
title_sort | microglial inhibition of neuroprotection by antagonists of the ep1 prostaglandin e2 receptor |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649915/ https://www.ncbi.nlm.nih.gov/pubmed/19222857 http://dx.doi.org/10.1186/1742-2094-6-5 |
work_keys_str_mv | AT carlsonnoelg microglialinhibitionofneuroprotectionbyantagonistsoftheep1prostaglandine2receptor AT rojasmonicaa microglialinhibitionofneuroprotectionbyantagonistsoftheep1prostaglandine2receptor AT blackjohndavid microglialinhibitionofneuroprotectionbyantagonistsoftheep1prostaglandine2receptor AT reddjonathanw microglialinhibitionofneuroprotectionbyantagonistsoftheep1prostaglandine2receptor AT hillejohn microglialinhibitionofneuroprotectionbyantagonistsoftheep1prostaglandine2receptor AT hillkennethe microglialinhibitionofneuroprotectionbyantagonistsoftheep1prostaglandine2receptor AT rosejohnw microglialinhibitionofneuroprotectionbyantagonistsoftheep1prostaglandine2receptor |